Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 18, 2026

Isomorphic Labs raises $5bn to advance drug pipeline

Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.

Isomorphic Labs manages both partnered initiatives and wholly owned drug development programmes. Credit: T. Schneider/Shutterstock.com.